GLYCOSYLATION OF THE INTERLEUKIN-1 RECEPTOR TYPE-I IS REQUIRED FOR OPTIMAL BINDING OF INTERLEUKIN-1

被引:0
|
作者
MANCILLA, J
IKEJIMA, T
DINARELLO, CA
机构
[1] NEW ENGLAND MED CTR,750 WASHINGTON ST,BOSTON,MA 02111
[2] TUFTS UNIV,SCH MED,DEPT MED,BOSTON,MA 02111
来源
LYMPHOKINE AND CYTOKINE RESEARCH | 1992年 / 11卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The two types of cell surface receptors for interleukin-1 (IL-1) are glycoproteins that contain N-glycosidic chains on their extracellular portions. To determine the role of glycosylation of the IL-1 receptor type I (IL-1RtI) in the binding and function of IL-1, we used four plant lectins and glycosidase treatment on two different T-cell lines (EL4-6.1 and D10S) and expressing high number of binding sites for IL-1. The lectins wheat germ agglutinin, phytohemagglutinin, and concanavalin A inhibited in a dose-response manner the IL-1-induced proliferation of D10S cells. Binding of IL-1 was blocked and radioactive IL-1 was displaced from these cells by these lectins. Specific sugars (GlcNAc, NeuAc, Gal-GlcNAc-Man, Man, or alpha-MeMan) did not themselves affect IL-1 binding but reversed the blocking effects of the lectins. The two cell lines differed in their responses to the lectin-mediated inhibition of IL-1 binding. Digestion by N-glycosidase significantly decreased the capacity of cells to bind IL-1, and reduced by approximately 20,000 D the M(r) of the IL-1RtI. Neuraminidase and O-glycanase treatment did not alter the binding of IL-1 to D10S or EL4-6.1 cells. This study demonstrates that glycosylation of the extracellular domain of the IL-1RtI is due to N-linked carbohydrates, that the degree of glycosylation can vary in cells of different lineage, and that this N-linked glycosylation appears to be essential for optimal binding and activity of IL-1 to its type I receptor.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [1] Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β
    Guy P. A. Vigers
    Lana J. Anderson
    Patricia Caffes
    Barbara J. Brandhuber
    [J]. Nature, 1997, 386 : 190 - 194
  • [2] Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1 beta
    Vigers, GPA
    Anderson, LJ
    Caffes, P
    Brandhuber, BJ
    [J]. NATURE, 1997, 386 (6621) : 190 - 194
  • [3] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [4] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    MANCILLA, J
    CLARK, BD
    DINARELLO, CA
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A462 - A462
  • [5] EX-VIVO PRODUCTION OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN TYPE-I DIABETES
    NETEA, MG
    HANCU, N
    CUCUIANU, M
    GRIGORESCUSIDO, P
    POPA, L
    POPA, V
    BLOK, WL
    VANDERMEER, JWM
    [J]. DIABETOLOGIA, 1994, 37 : A96 - A96
  • [6] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01): : 38 - 41
  • [7] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
  • [8] Interleukin-1 receptor accessory protein is required for interleukin-1 signalling
    Martin, M
    Wesche, H
    Resch, K
    Lang, D
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 302 - 302
  • [9] NUCLEAR INTERNALIZATION AND DNA-BINDING ACTIVITIES OF INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR COMPLEXES
    WEITZMANN, MN
    SAVAGE, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (02) : 1166 - 1171
  • [10] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619